Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Management of asymptomatic bacteriuria after kidney transplantation: what is the quality of the evidence behind the IDSA guidelines?

Coussement J, Scemla A, Abramowicz D, Nagler EV, Webster AC.

Clin Infect Dis. 2019 Jun 13. pii: ciz503. doi: 10.1093/cid/ciz503. [Epub ahead of print] No abstract available.

PMID:
31190055
2.

WITHDRAWN: [Infectious complications after kidney transplantation].

Scemla A, Manda V.

Nephrol Ther. 2019 Apr;15 Suppl 1:S37-S42. doi: 10.1016/j.nephro.2019.03.010. French.

PMID:
30981394
3.

The Case | Posttransplant upper limb inflammatory nodules.

Brunel M, Leclerc-Mercier S, Barnier JP, Bille E, Sberro-Soussan R, Legendre C, Scemla A.

Kidney Int. 2019 Mar;95(3):721-722. doi: 10.1016/j.kint.2018.10.012. No abstract available.

PMID:
30784666
4.

Conversion from calcineurin inhibitors to belatacept in HLA- sensitized kidney-transplant recipients with low-level donor specific antibodies.

Ulloa CE, Anglicheau D, Snanoudj R, Scemla A, Martinez F, Timsit MO, Legendre C, Sberro-Soussan R.

Transplantation. 2019 Jan 30. doi: 10.1097/TP.0000000000002592. [Epub ahead of print]

PMID:
30720681
5.

Baseline graft status is a critical predictor of kidney graft failure after diarrhoea.

Devresse A, Morin L, Aulagnon F, Taupin JL, Scemla A, Lanternier F, Aubert O, Aidoud AA, Lebreton X, Sberro-Soussan R, Snanoudj R, Amrouche L, Tinel C, Martinez F, Bererhi L, Anglicheau D, Lortholary O, Legendre C, Avettand-Fenoel V, Zuber J.

Nephrol Dial Transplant. 2019 Jan 3. doi: 10.1093/ndt/gfy386. [Epub ahead of print]

PMID:
30608553
6.

No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experience.

Devresse A, Tinel C, Vermorel A, Snanoudj R, Morin L, Avettand-Fenoel V, Amrouche L, Scemla A, Zuber J, Legendre C, Rabant M, Anglicheau D.

Transpl Int. 2019 May;32(5):481-492. doi: 10.1111/tri.13392. Epub 2019 Jan 11.

PMID:
30565748
7.

Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area.

Gras J, De Castro N, Montlahuc C, Champion L, Scemla A, Matignon M, Lachâtre M, Raskine L, Grall N, Peraldi MN, Molina JM.

Transpl Infect Dis. 2018 Oct;20(5):e12943. doi: 10.1111/tid.12943. Epub 2018 Jun 28.

PMID:
29890021
8.

Failure of voriconazole therapy due to acquired azole resistance in Aspergillus fumigatus in a kidney transplant recipient with chronic necrotizing aspergillosis.

Pilmis B, Garcia-Hermoso D, Alanio A, Catherinot E, Scemla A, Jullien V, Bretagne S, Lortholary O.

Am J Transplant. 2018 Sep;18(9):2352-2355. doi: 10.1111/ajt.14940. Epub 2018 Jul 12.

PMID:
29790292
9.

Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe.

Coussement J, Maggiore U, Manuel O, Scemla A, López-Medrano F, Nagler EV, Aguado JM, Abramowicz D; European Renal Association-European Dialysis Transplant Association (ERA-EDTA) Developing Education Science and Care for Renal Transplantation in European States (DESCARTES) working group and the European Study Group for Infections in Compromised Hosts (E; COLLABORATORS (IN ALPHABETICAL ORDER) ; European Renal Association-European Dialysis Transplant Association (ERA-EDTA) Developing Education Science and Care for Renal Transplantation in European States (DESCARTES) working group and the European Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

Nephrol Dial Transplant. 2018 Sep 1;33(9):1661-1668. doi: 10.1093/ndt/gfy078.

PMID:
29635410
10.

Clinical Assessment of a Nocardia PCR-Based Assay for Diagnosis of Nocardiosis.

Rouzaud C, Rodriguez-Nava V, Catherinot E, Méchaï F, Bergeron E, Farfour E, Scemla A, Poirée S, Delavaud C, Mathieu D, Durupt S, Larosa F, Lengelé JP, Christophe JL, Suarez F, Lortholary O, Lebeaux D.

J Clin Microbiol. 2018 May 25;56(6). pii: e00002-18. doi: 10.1128/JCM.00002-18. Print 2018 Jun.

11.

Antibiotics for asymptomatic bacteriuria in kidney transplant recipients.

Coussement J, Scemla A, Abramowicz D, Nagler EV, Webster AC.

Cochrane Database Syst Rev. 2018 Feb 1;2:CD011357. doi: 10.1002/14651858.CD011357.pub2. Review.

12.

Reduction in late onset cytomegalovirus primary disease after discontinuation of antiviral prophylaxis in kidney transplant recipients treated with de novo everolimus.

Devresse A, Leruez-Ville M, Scemla A, Avettand-Fenoel V, Morin L, Lebreton X, Tinel C, Amrouche L, Lamhaut L, Timsit MO, Zuber J, Legendre C, Anglicheau D.

Transpl Infect Dis. 2018 Apr;20(2):e12846. doi: 10.1111/tid.12846. Epub 2018 Feb 21.

PMID:
29360195
13.

Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature review.

Rouzaud C, Chosidow O, Brocard A, Fraitag S, Scemla A, Anglicheau D, Bouaziz JD, Dupin N, Bougnoux ME, Hay R, Lortholary O, Lanternier F; French Mycoses Study Group.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12799. Epub 2018 Jan 25.

PMID:
29094463
14.

Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.

Levi C, Frémeaux-Bacchi V, Zuber J, Rabant M, Devriese M, Snanoudj R, Scemla A, Amrouche L, Mejean A, Legendre C, Sberro-Soussan R.

Transplantation. 2017 Dec;101(12):2924-2930. doi: 10.1097/TP.0000000000001909.

PMID:
28858176
15.

Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.

López-Medrano F, Fernández-Ruiz M, Silva JT, Carver PL, van Delden C, Merino E, Pérez-Saez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín-Moreno PL, Len Ó, Rudas E, Ponce de León A, Arriola M, Lauzurica R, David MD, González-Rico C, Henríquez-Palop F, Fortún J, Nucci M, Manuel O, Paño-Pardo JR, Montejo M, Vena A, Sánchez-Sobrino B, Mazuecos A, Pascual J, Horcajada JP, Lecompte T, Moreno A, Carratalà J, Blanes M, Hernández D, Hernández-Méndez EA, Fariñas MC, Perelló-Carrascosa M, Muñoz P, Andrés A, Aguado JM; Spanish Network for Research in Infectious Diseases (REIPI); Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC); Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Swiss Transplant Cohort Study (STCS).

Clin Microbiol Infect. 2018 Feb;24(2):192-198. doi: 10.1016/j.cmi.2017.06.016. Epub 2017 Jun 23.

16.

Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program.

Amrouche L, Aubert O, Suberbielle C, Rabant M, Van Huyen JD, Martinez F, Sberro-Soussan R, Scemla A, Tinel C, Snanoudj R, Zuber J, Cavalcanti R, Timsit MO, Lamhaut L, Anglicheau D, Loupy A, Legendre C.

Transplantation. 2017 Oct;101(10):2440-2448. doi: 10.1097/TP.0000000000001650.

PMID:
28114171
17.

Prognosis of Invasive Aspergillosis in Kidney Transplant Recipients: A Case-Control Study.

Desbois AC, Poiree S, Snanoudj R, Bougnoux ME, Sberro-Soussan R, Lanternier F, Legendre C, Lortholary O, Scemla A.

Transplant Direct. 2016 Jul 1;2(8):e90. eCollection 2016 Aug.

18.

Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study.

López-Medrano F, Fernández-Ruiz M, Silva JT, Carver PL, van Delden C, Merino E, Pérez-Saez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín-Moreno PL, Len Ó, Rudas E, de León AP, Arriola M, Lauzurica R, David M, González-Rico C, Henríquez-Palop F, Fortún J, Nucci M, Manuel O, Paño-Pardo JR, Montejo M, Muñoz P, Sánchez-Sobrino B, Mazuecos A, Pascual J, Horcajada JP, Lecompte T, Moreno A, Carratalà J, Blanes M, Hernández D, Fariñas MC, Andrés A, Aguado JM; Spanish Network for Research in Infectious Diseases (REIPI), the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), the Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the Swiss Transplant Cohort Study (STCS).

Am J Transplant. 2016 Nov;16(11):3220-3234. doi: 10.1111/ajt.13837. Epub 2016 May 31.

19.

Cryptosporidium spp. Infection in Solid Organ Transplantation: The Nationwide "TRANSCRYPTO" Study.

Lanternier F, Amazzough K, Favennec L, Mamzer-Bruneel MF, Abdoul H, Tourret J, Decramer S, Zuber J, Scemla A, Legendre C, Lortholary O, Bougnoux ME; ANOFEL Cryptosporidium National Network and Transplant Cryptosporidium Study Group.

Transplantation. 2017 Apr;101(4):826-830. doi: 10.1097/TP.0000000000001503.

PMID:
27681270
20.

Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.

Angebault C, Lanternier F, Dalle F, Schrimpf C, Roupie AL, Dupuis A, Agathine A, Scemla A, Paubelle E, Caillot D, Neven B, Frange P, Suarez F, d'Enfert C, Lortholary O, Bougnoux ME.

Open Forum Infect Dis. 2016 Jun 16;3(3):ofw128. doi: 10.1093/ofid/ofw128. eCollection 2016 Sep.

21.

Pauci-immune crescentic glomerulonephritis without ANCA in a patient presenting with Candida parapsilosis endocarditis.

Scemla A, Charlier C, Noel LH, Amazzough K, Von Rosen FT, Lesavre P, Lortholary O.

Med Mal Infect. 2016 May;46(3):163-5. doi: 10.1016/j.medmal.2016.01.004. Epub 2016 Feb 17. No abstract available.

PMID:
26897307
22.

Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case-Control Study.

López-Medrano F, Silva JT, Fernández-Ruiz M, Carver PL, van Delden C, Merino E, Pérez-Saez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín-Moreno PL, Len Ó, Rudas E, de León AP, Arriola M, Lauzurica R, David M, González-Rico C, Henríquez-Palop F, Fortún J, Nucci M, Manuel O, Paño-Pardo JR, Montejo M, Muñoz P, Sánchez-Sobrino B, Mazuecos A, Pascual J, Horcajada JP, Lecompte T, Lumbreras C, Moreno A, Carratalà J, Blanes M, Hernández D, Hernández-Méndez EA, Fariñas MC, Perelló-Carrascosa M, Morales JM, Andrés A, Aguado JM; Spanish Network for Research in Infectious Diseases (REIPI), the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), the Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the Swiss Transplant Cohort Study (STCS).

Am J Transplant. 2016 Jul;16(7):2148-57. doi: 10.1111/ajt.13735. Epub 2016 Mar 10.

23.

Acquired Flucytosine Resistance during Combination Therapy with Caspofungin and Flucytosine for Candida glabrata Cystitis.

Charlier C, El Sissy C, Bachelier-Bassi S, Scemla A, Quesne G, Sitterlé E, Legendre C, Lortholary O, Bougnoux ME.

Antimicrob Agents Chemother. 2015 Nov 2;60(1):662-5. doi: 10.1128/AAC.02265-15. Print 2016 Jan.

24.

ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence.

Pilmis B, Scemla A, Join-Lambert O, Mamzer MF, Lortholary O, Legendre C, Zahar JR.

Infect Dis (Lond). 2015;47(10):714-8. doi: 10.3109/23744235.2015.1051107. Epub 2015 May 29.

PMID:
26024285
25.

Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.

Rabant M, Amrouche L, Lebreton X, Aulagnon F, Benon A, Sauvaget V, Bonifay R, Morin L, Scemla A, Delville M, Martinez F, Timsit MO, Duong Van Huyen JP, Legendre C, Terzi F, Anglicheau D.

J Am Soc Nephrol. 2015 Nov;26(11):2840-51. doi: 10.1681/ASN.2014080797. Epub 2015 May 6.

26.

Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region.

Danion F, Belissa E, Peytavin G, Thierry E, Lanternier F, Scemla A, Lortholary O, Delelis O, Avettand-Fenoel V, Duvivier C.

J Antimicrob Chemother. 2015;70(6):1921-3. doi: 10.1093/jac/dkv012. Epub 2015 Feb 10. No abstract available.

PMID:
25670643
27.

Dramatic improvement of severe cryptococcosis-induced immune reconstitution syndrome with adalimumab in a renal transplant recipient.

Scemla A, Gerber S, Duquesne A, Parize P, Martinez F, Anglicheau D, Snanoudj R, Zuber M, Bougnoux ME, Legendre C, Lortholary O.

Am J Transplant. 2015 Feb;15(2):560-4. doi: 10.1111/ajt.13002. Epub 2015 Jan 21.

28.

[Current aspects of acute humoral rejection].

Legendre C, Loupy A, Rabant M, Aubert O, Rabaté C, Delville M, Tinel C, Amrouche L, Martinez F, Snanoudj R, Bererhi L, Scemla A, Sberro-Soussan R, Duong JP, Suberbielle C, Anglicheau D.

Nephrol Ther. 2014 Nov;10(6):479-83. doi: 10.1016/j.nephro.2014.09.001. Epub 2014 Oct 16. Review. French.

PMID:
25440942
29.

Mucor irregularis-associated cutaneous mucormycosis: Case report and review.

Rammaert B, Angebault C, Scemla A, Fraitag S, Lerolle N, Lecuit M, Bougnoux ME, Lortholary O.

Med Mycol Case Rep. 2014 Jul 24;6:62-5. doi: 10.1016/j.mmcr.2014.07.005. eCollection 2014 Oct.

30.

Diarrhea after kidney transplantation: a new look at a frequent symptom.

Aulagnon F, Scemla A, DeWolf S, Legendre C, Zuber J.

Transplantation. 2014 Oct 27;98(8):806-16. doi: 10.1097/TP.0000000000000335. Review.

PMID:
25073040
31.

Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies.

Aubert O, Bories MC, Suberbielle C, Snanoudj R, Anglicheau D, Rabant M, Martinez F, Scemla A, Legendre C, Sberro-Soussan R.

Am J Transplant. 2014 Jun;14(6):1439-45. doi: 10.1111/ajt.12709. Epub 2014 May 7.

32.

Autoimmune neutropenia after kidney transplantation: a disregarded entity of posttransplant neutropenia.

Aubert O, Sberro-Soussan R, Scemla A, Casadevall N, Teyssandier I, Martinez F, Hermine O, Legendre C, Varet B, De Fontbrune FS.

Transplantation. 2014 Apr 15;97(7):725-9. doi: 10.1097/TP.0000000000000109.

PMID:
24598937
33.

The kidney as a reservoir for HIV-1 after renal transplantation.

Canaud G, Dejucq-Rainsford N, Avettand-Fenoël V, Viard JP, Anglicheau D, Bienaimé F, Muorah M, Galmiche L, Gribouval O, Noël LH, Satie AP, Martinez F, Sberro-Soussan R, Scemla A, Gubler MC, Friedlander G, Antignac C, Timsit MO, Onetti Muda A, Terzi F, Rouzioux C, Legendre C.

J Am Soc Nephrol. 2014 Feb;25(2):407-19. doi: 10.1681/ASN.2013050564. Epub 2013 Dec 5.

34.

Nocardiosis in transplant recipients.

Lebeaux D, Morelon E, Suarez F, Lanternier F, Scemla A, Frange P, Mainardi JL, Lecuit M, Lortholary O.

Eur J Clin Microbiol Infect Dis. 2014 May;33(5):689-702. doi: 10.1007/s10096-013-2015-5. Epub 2013 Nov 23. Review.

PMID:
24272063
35.

The case | Post-tranplant allograft dysfunction.

Aubert O, Galmiche L, Rozenberg F, Duquesne A, Scemla A, Rabant M, Leruez M, Laude H, Legendre C, Sberro-Soussan R.

Kidney Int. 2013 Apr;83(4):765-7. doi: 10.1038/ki.2013.1. No abstract available.

36.

I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y.

LeGoff J, Rousset D, Abou-Jaoudé G, Scemla A, Ribaud P, Mercier-Delarue S, Caro V, Enouf V, Simon F, Molina JM, van der Werf S.

PLoS One. 2012;7(8):e37095. doi: 10.1371/journal.pone.0037095. Epub 2012 Aug 24.

37.

[Pneumocystis jirovecii pneumonia in HIV-infected patients].

De Castro N, Scemla A, Gallien S, Molina JM.

Rev Mal Respir. 2012 Jun;29(6):793-802. doi: 10.1016/j.rmr.2011.10.975. Epub 2012 May 14. Review. French.

PMID:
22742466
38.

High burden of non-influenza viruses in influenza-like illness in the early weeks of H1N1v epidemic in France.

Schnepf N, Resche-Rigon M, Chaillon A, Scemla A, Gras G, Semoun O, Taboulet P, Molina JM, Simon F, Goudeau A, LeGoff J.

PLoS One. 2011;6(8):e23514. doi: 10.1371/journal.pone.0023514. Epub 2011 Aug 17.

39.

Severe acute renal failure in an HIV-infected patient after only 2 weeks of tenofovir-based antiretroviral therapy.

Pavie J, Scemla A, Bouldouyre MA, Pillebout E, Verine J, Molina JM.

AIDS Patient Care STDS. 2011 Aug;25(8):457-60. doi: 10.1089/apc.2011.0056. Epub 2011 Jul 13.

PMID:
21751874
40.

Pandemic Influenza A (H1N1) Infection among HIV-Infected Adults in France.

Tourdjman M, Chea S, Goff JL, De Verdiere NC, Scemla A, Pavie J, Simon F, Molina JM.

J Int Assoc Physicians AIDS Care (Chic). 2011 Jul-Aug;10(4):229-31. doi: 10.1177/1545109711407504. Epub 2011 May 12.

PMID:
21566102
41.

Chronic interstitial nephritis in an HIV type-1-infected patient receiving ritonavir-boosted atazanavir.

Viglietti D, Verine J, De Castro N, Scemla A, Daudon M, Glotz D, Pillebout E.

Antivir Ther. 2011;16(1):119-21. doi: 10.3851/IMP1700.

PMID:
21311116
42.

Incidence of infectious complications in highly sensitized renal transplant recipients treated by rituximab: a case-controlled study.

Scemla A, Loupy A, Candon S, Mamzer MF, Martinez F, Zuber J, Sberro R, Legendre C, Thervet E.

Transplantation. 2010 Dec 15;90(11):1180-4. doi: 10.1097/TP.0b013e3181fa941b.

PMID:
20885337
43.

Less pessimistic long-term results for patients with cytomegalovirus disease.

Scemla A, Kreis H, Legendre C.

Clin Infect Dis. 2008 Nov 15;47(10):1360-1; author reply 1361-2. doi: 10.1086/592749. No abstract available.

PMID:
18922073

Supplemental Content

Loading ...
Support Center